Biotechnological Approaches to Hemostasis and Molecular Mechanisms of Wound Healing

Part of the Updates in Surgery book series (UPDATESSURG, volume 0)


Wounds today remain a difficult clinical problem due to early or late complications that are a frequent cause of mortality. To try to resolve this problem, many studies have focused on understanding physiologic healing and wound care, with particular emphasis on new therapeutic approaches and the continued development of biotechnology for the management of acute and long term injuries. Normal wound healing is a dynamic and complex process involving a series of coordinated events, including bleeding, coagulation, initiation of an acute inflammatory response to the initial injury, regeneration, migration and proliferation of connective tissue and parenchyma cells, as well as synthesis of extracellular matrix proteins, remodeling of new parenchyma and connective tissue and collagen deposition. Lastly, increasing wound strength takes place in an ordered manner and culminates in the repair of severed tissues [1.


Fibrin Sealant Biphasic Calcium Phosphate Difficult Clinical Problem Macroporous Biphasic Calcium Phosphate Blood Salvage System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Velnar T, Bailey T, Smrkoly V (2009) The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37:1528–1542PubMedGoogle Scholar
  2. 2.
    Sartelli M (2008) The use of floseal haemostatic sealant in surgical haemorrhage. In: Sartelli M, Catena F (eds) Emergency surgery manual. Alpes, Rome, pp. 617–626Google Scholar
  3. 3.
    Izzo F, Di Marzo M, Idà ND, Piccirillo M (2008) Hemostat, adhesives and sealants: the biomaterials. In: Sartelli M, Catena F (eds) Emergency surgery manual. Alpes, Rome, pp. 611–616Google Scholar
  4. 4.
    Spotnitz DW (2010) Fibrin sealant: past, present, and future: a brief review. World J Surg 34:632–634CrossRefPubMedGoogle Scholar
  5. 5.
    Spotnitz WD, Burks S (2008) Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 48:1502–1516CrossRefPubMedGoogle Scholar
  6. 6.
    Seyednejad H, Imani M, Jamieson T, Seifalian AM (2008) Topical haemostatic agents. Brit J Surg 95:1197–1225CrossRefPubMedGoogle Scholar
  7. 7.
    Gibble JW, Ness PM (1990) Fibrin glue: the perfect operative sealant Transfsion 30:741–747CrossRefGoogle Scholar
  8. 8.
    Martinowitz U, Schulman S (1995) Fibrin sealant in surgery of patients with a hemorrhagic diathesis. Thromb Haemostasis 74:486–492Google Scholar
  9. 9.
    Radosevich M, Goubran HA, Burnouf T (1997) Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 72:133–143CrossRefPubMedGoogle Scholar
  10. 10.
    Alving BM, Weinstein JS, Finlayson JE et al (1995) Fibrin sealant: summary of a conference on characteristics and clinical use. Transfusion 35:783–790CrossRefPubMedGoogle Scholar
  11. 11.
    Dunn CJ, Goa KL (1999) Fibrin sealant: a review of its use in surgery and endoscopy. Drugs 58:863–886CrossRefPubMedGoogle Scholar
  12. 12.
    Kjaergard HK, Fairbrother JE (1996) Controlled clinical studies of fibrin sealant in cardiothoracic surgery. A review. Eur J Cardithorac Surg 10:727–733CrossRefGoogle Scholar
  13. 13.
    Panyam EJ, Labhasetwar V (2003) Biodegradable nano-particles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 55:329–347CrossRefGoogle Scholar
  14. 14.
    Powell JS (2007) Liposomal approach towards the development of a longer-acting factor VIII. Haemophilia 13[Suppl 2]:23–28CrossRefPubMedGoogle Scholar
  15. 15.
    Marsh JN, Senpan A, Hu G et al (2007) Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed 2:533–543CrossRefGoogle Scholar
  16. 16.
    Chenglong D, Yuan Y, Changsheng L et al (2009) Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control. Biomaterials 30:5364–5375CrossRefGoogle Scholar
  17. 17.
    Ellis-Behnke RG, Liang YX, Tay DK et al (2006) Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine 2:207–215PubMedGoogle Scholar
  18. 18.
    Aust MC, Knobloch K, Reimers K (2010) Percutaneous collagen induction therapy: an alternative treatment for burn scars. Burns doi:10.1016/j.burns.2009.11.014Google Scholar
  19. 19.
    Hanson SE, Bentz ML, Hematti P (2010) Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 125:510–516CrossRefPubMedGoogle Scholar
  20. 20.
    Jeong JH (2010) Adipose stem cells and skin repair. Curr Stem Cell Res Ther 5:137–140CrossRefPubMedGoogle Scholar
  21. 21.
    Hong YM, Loughlin KR (2006) The use of hemostatic agents and sealants in urology. J Urology 176:2367–2374CrossRefGoogle Scholar
  22. 22.
    Lee LT, Kwan PC, Chen YF, Wong YK (2008) Comparison of the effectiveness of autologous fibrin glue and macroporous biphasic calcium phosphate as carriers in the osteogenesis process with or without mesenchymal stem cells. J Chin Med Assoc 71:66–73CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2011

Authors and Affiliations

  1. 1.Department of Anesthesiological, Surgical and Emergency SciencesSecond University of NaplesNaplesItaly

Personalised recommendations